Human subject research

Results: 1674



#Item
331Clinical research / Pharmacology / Drug safety / Institutional review board / Investigational New Drug / Food and Drug Administration / Regulatory requirement / Clinical investigator / Investigational Device Exemption / Research / Medicine / Health

DANA-FARBER / HARVARD CANCER CENTER STANDARD OPERATING PROCEDURES FOR HUMAN SUBJECT RESEARCH TITLE: Protocol Specific Training Requirements SOP #: EDU-100 (formerly ET-203) Page: 1 of 3

Add to Reading List

Source URL: www.dfhcc.harvard.edu

Language: English - Date: 2014-09-18 14:55:03
332Medicine / Pharmaceutical industry / Clinical Data Management / Design of experiments / Pharmacology / Case report form / Dana–Farber Cancer Institute / Investigational Device Exemption / Clinical trial / Clinical research / Research / Science

DANA-FARBER / HARVARD CANCER CENTER STANDARD OPERATING PROCEDURES FOR HUMAN SUBJECT RESEARCH TITLE Case Report Form (CRF) Design for PI-Initiated Protocols SOP #: DATA-101 (formerly QA-715) Page: 1 of 6

Add to Reading List

Source URL: www.dfhcc.harvard.edu

Language: English - Date: 2014-02-20 14:53:05
333Science / Clinical research / Research ethics / Biological databases / Biobanks / Biobank / Informed consent / Institutional review board / Human subject research / Ethics / Medical ethics / Applied ethics

http://www.eurecnet.org/newsletter Newsletter 2014 / 01 Informed Consent and Data Protection in Multicenter Genetic-Neuroimaging Studies

Add to Reading List

Source URL: www.eurecnet.org

Language: English - Date: 2014-11-13 05:14:24
334Clinical research / Design of experiments / Pharmacology / Drug safety / Auditing / Institutional review board / Clinical trial / Audit committee / Clinical investigator / Research / Medicine / Health

DANA-FARBER / HARVARD CANCER CENTER STANDARD OPERATING PROCEDURES FOR HUMAN SUBJECT RESEARCH TITLE: Training Requirements for New Overall Principal Investigators SOP #: EDU-105 (formerly QA-723) Page: 1 of 3

Add to Reading List

Source URL: www.dfhcc.harvard.edu

Language: English - Date: 2014-09-18 14:55:03
335Pharmacology / Clinical research / Food and Drug Administration / Pharmaceutical industry / Medical research / Investigational New Drug / Clinical trial / Pharmacy / Clinical investigator / Research / Pharmaceutical sciences / Health

DANA-FARBER / HARVARD CANCER CENTER STANDARD OPERATING PROCEDURES FOR HUMAN SUBJECT RESEARCH TITLE: Return of Unused Investigational Drug from Subject to the Pharmacy SOP #: INV-102 (formerly PM-404) Page: 1 of 3

Add to Reading List

Source URL: www.dfhcc.harvard.edu

Language: English - Date: 2014-02-20 22:11:49
336Design of experiments / Pharmacology / Food and Drug Administration / Medicine / Drug safety / Clinical trial / Institutional review board / Protocol / Investigational New Drug / Clinical research / Science / Research

DANA-FARBER / HARVARD CANCER CENTER STANDARD OPERATING PROCEDURES FOR HUMAN SUBJECT RESEARCH TITLE: Data and Safety Monitoring Committee (DSMC) Data Submission Compliance SOP #: DATA-104 (formerly QA-724) Page: 1 of 4

Add to Reading List

Source URL: www.dfhcc.harvard.edu

Language: English - Date: 2014-02-20 14:53:12
337El Salvador / Criminal law / Law / Military of El Salvador / National Guard / José Guillermo García / Forced disappearance / Torture / Extrajudicial punishment / Salvadoran Civil War / Ethics / Human rights abuses

DANA-FARBER / HARVARD CANCER CENTER STANDARD OPERATING PROCEDURES FOR HUMAN SUBJECT RESEARCH TITLE: Good Clinical Practice Training Requirement for New Clinical Trial Researchers SOP #: EDU-103 (formerly ET-205) Page: 1

Add to Reading List

Source URL: www.dfhcc.harvard.edu

Language: English - Date: 2014-02-20 09:19:40
338Clinical research / Pharmacology / Pharmaceutical industry / Design of experiments / Institutional review board / Clinical trial / Dana–Farber Cancer Institute / Investigational New Drug / Investigational Device Exemption / Medicine / Research / Health

DANA-FARBER / HARVARD CANCER CENTER STANDARD OPERATING PROCEDURES FOR HUMAN SUBJECT RESEARCH TITLE: Conducting PI-Initiated Multi-center Trials SOP #: MULTI-100 (formerly PM-402) Page: 1 of 7

Add to Reading List

Source URL: www.dfhcc.harvard.edu

Language: English - Date: 2014-09-18 14:57:14
339Research ethics / Medical ethics / Research / Design of experiments / Pharmacology / Institutional review board / Human subject research / Applied ethics / Ethics / Clinical research

GUIDELINES FOR DRAFTING PARTICIPANT INFORMATION SHEET & CONSENT FORMS (PICF) The National Health & Medical Research Council (NHMRC) National Statement on Ethical Conduct in Human Research, 2007 advises “Respect for hum

Add to Reading List

Source URL: www.mater.org.au

Language: English - Date: 2014-11-27 01:08:00
340Clinical research / Pharmaceutical industry / Pharmacology / Dana–Farber Cancer Institute / Harvard Medical School / Clinical trial / Investigational Device Exemption / Regulatory requirement / Food and Drug Administration / Research / Medicine / Pharmaceutical sciences

DANA-FARBER / HARVARD CANCER CENTER STANDARD OPERATING PROCEDURES FOR HUMAN SUBJECT RESEARCH TITLE: Training Requirements for DF/HCC Sponsors and new DF/HCC Sponsor Team Personnel of DF/HCC Multi-Center Trials SOP #: MUL

Add to Reading List

Source URL: www.dfhcc.harvard.edu

Language: English - Date: 2014-09-18 14:57:14
UPDATE